Ceramide
Reactions involving Ceramide
Every recorded step where this molecule takes part
-
Ceramide + phosphatidylcholine -> sphingomyelin + diacylglycerol
-
Ceramide + UDP-glucose -> glucosylceramide + UDP
-
Sphingomyelin + H2O -> ceramide + phosphocholine
-
Glucosylceramide -> ceramide + glucose
-
Galactocerebroside -> ceramide + galactose
-
Dihydroceramide -> ceramide
Showing all 6 reactions.
Pathway junctions through this molecule
Produced in one pathway, consumed in another
| Produced in | Consumed in | Link | |
|---|---|---|---|
| Sphingolipid Degradation (Lysosomal) | → | Sphingolipid Synthesis | within category |
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Xiegan Liangxue Jiedu Decoction ameliorates psychiatric comorbidities in psoriasis via regulation of sphingolipid metabolism.
Ping L, Yan SJ, Chen L, Zhang CL, Yao YQ, Li XR, Song Y, Gao SP, Gong Y, Yang Y, Gu J. · 2026-07-22
unreviewed -
2
Exploratory comparison of extracellular proteomic, metabolomic, and lipidomic profiling of inulin-fortified gelatin capsule waste gel fermented by <i>Lactiplantibacillus plantarum</i>.
Kingwascharapong P, Uchuwittayakul A. · 2026-07-28
unreviewed -
3
<i>Lactobacillus johnsonii</i> mediates the protective effects of pristimerin against ulcerative colitis and concomitant liver injury through remodeling hepatic lipid metabolism via LXRα-SCD1 axis.
Cheng Y, Wu ZE, Huang R, Li Q, Yan D, Chen Y, Zhu W, Li F. · 2026-07-17
unreviewed -
4
Metabolic profile association with white matter hyperintensity in patients with mild cognitive impairment.
Ariaei A, Zamiri R, Ghasemi A, Rezayani B, Rezayani S, Ezatpour A, Farshidi N, Sheikhi EA, Roghanian A, Alzhe… · 2026-06-09
open access unreviewed -
5
MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.
Kisielewska M, Suwała S, Drąg-Zalesińska M, Rembiałkowska N. · 2026-06-15
open access unreviewed -
6
Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib.
Huang F, Zhan P, Shi X, Sun Y, Song X, Sun P, Liu B. · 2026-05-22
open access unreviewed -
7
Leucine-rich repeat kinase 2 (LRRK2): balancing cellular homeostasis and Parkinson's disease (PD) pathogenesis.
Aolymat I, Abu-Hassan DW, Oleimat AK, Sameer W, Wreikat B, Iqilan T, Al-Momani H, Ali H, Tahtamouni L, Iqsair… · 2026-06-03
open access unreviewed -
8
Multi-omics integration reveals convergent extracellular matrix remodelling and lipid metabolic reprogramming as central axes of adipocyte differentiation from mouse embryonic stem cells.
Al-Sayegh M, Khalili M, Alzaabi M, Sultana M, Ali L, Ali M, El-Hadidi M. · 2026-06-02
open access unreviewed -
9
Integrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis.
Liu S, Xia Y, Ding L, Zhang M, Wang W, Zhou J, Liu L. · 2026-05-31
open access unreviewed -
10
The role of protein palmitoylation in disease pathogenesis and therapeutic innovation.
Lin X, Xing J, Jia K, Liu S, Liu Y, Gu Y, Guo K, Yi J. · 2026-05-29
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.